Mureletecan Uses, Dosage, Side Effects and more
Mureletecan is under investigation in clinical trial NCT00004076 (PNU 166148 in Treating Patients With Metastatic Solid Tumors).
| Trade Name | Mureletecan |
| Generic | Mureletecan |
| Mureletecan Other Names | Mureletecan |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
